PAVmed Inc (STU:1P50)
€ 2.78999 0 (0%) Market Cap: 10.40 Mil Enterprise Value: 36.24 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 37/100

Q3 2019 PAVmed Inc Earnings Call Transcript

Nov 21, 2019 / 09:30PM GMT
Release Date Price: €9.74 (-1.90%)
Operator

Greetings, and welcome to the PAVmed Business

Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the conference over to our host, Mike Havrilla, Director of Investor Relations for PAVmed. Thank you. You may begin.

Mike Havrilla
PAVmed Inc. - Director of IR

Good afternoon, everyone. This is Mike Havrilla, PAVmed's Director of Investor Relations. Thank you all for participating in today's business update conference call. Joining me today on the call are Dr. Lishan Aklog, Chairman and Chief Executive Officer; and Dennis McGrath, President and Chief Financial Officer.

Before we begin, I'd like to caution that comments made during this conference call by management will contain forward-looking statements regarding the operations and future results of PAVmed. I encourage you to review the company's filings with the Securities and Exchange Commission to identify specific factors that may cause actual results or events to differ materially from those described in the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot